drugset / Trial / NCT00283361

ZP120 Add-on to Furosemide in Treatment of Acute or Sub-Acute Decompensated Heart Failure

NCT00283361 ↗

Phase 2 Terminated 130 enrolled Zealand Pharma Syneos Health · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The main purpose of this study is to see if the experimental drug ZP120, when given with the approved drug furosemide to patients with acute or sub-acute heart failure, can reduce the amount of fluid in the patients' lungs and make breathing easier.

Timeline

Start
2006-01
Primary completion
—
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject SER100 Protein / enzyme biologic — Intravenous